MXPA05009602A - Composiciones novedosas. - Google Patents

Composiciones novedosas.

Info

Publication number
MXPA05009602A
MXPA05009602A MXPA05009602A MXPA05009602A MXPA05009602A MX PA05009602 A MXPA05009602 A MX PA05009602A MX PA05009602 A MXPA05009602 A MX PA05009602A MX PA05009602 A MXPA05009602 A MX PA05009602A MX PA05009602 A MXPA05009602 A MX PA05009602A
Authority
MX
Mexico
Prior art keywords
compositions containing
novel compositions
containing fentanyl
fentanyl
formulations
Prior art date
Application number
MXPA05009602A
Other languages
English (en)
Spanish (es)
Inventor
Campbell Alistair
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0305579.5A external-priority patent/GB0305579D0/en
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of MXPA05009602A publication Critical patent/MXPA05009602A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA05009602A 2003-03-11 2004-03-11 Composiciones novedosas. MXPA05009602A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0305579.5A GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions
GB0328023A GB2399286A (en) 2003-03-11 2003-12-03 Sub-lingual fentanyl formulation
PCT/GB2004/001037 WO2004080382A2 (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl

Publications (1)

Publication Number Publication Date
MXPA05009602A true MXPA05009602A (es) 2005-11-08

Family

ID=32992592

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05009602A MXPA05009602A (es) 2003-03-11 2004-03-11 Composiciones novedosas.

Country Status (10)

Country Link
EP (1) EP1608372A2 (de)
JP (1) JP2006519770A (de)
KR (1) KR20050115276A (de)
AU (1) AU2004218876B2 (de)
BR (1) BRPI0408209A (de)
CA (1) CA2516338A1 (de)
MX (1) MXPA05009602A (de)
NO (1) NO20054172L (de)
NZ (1) NZ541781A (de)
WO (1) WO2004080382A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5577021B2 (ja) * 2005-02-17 2014-08-20 アボット・ラボラトリーズ 動物における障害を治療および予防するための薬剤組成物の経粘膜投与
GB0514043D0 (en) * 2005-07-08 2005-08-17 Arakis Ltd Fentanyl formulation
DK1976521T3 (en) 2006-01-25 2015-04-27 Insys Therapeutics Inc Sublingual fentanyl spray
PT2180844T (pt) 2007-08-02 2018-04-06 Insys Dev Co Inc Nebulizador sub-lingual de fentanilo
GB2476494A (en) * 2009-12-24 2011-06-29 Norwich Pharma Technologies Ltd Formulation for the sublingual delivery of sufentanil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2201358C (en) * 1994-09-30 2004-06-08 Jurgen Regenold Pharmaceutical composition
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
EP2042161A1 (de) * 1997-10-01 2009-04-01 Novadel Pharma Inc. Treibmittelfreie Sprayzusammensetzung enthaltend ein Antiemetikum
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
WO2000047203A1 (en) * 1999-02-12 2000-08-17 Mqs, Inc. Formulation and system for intra-oral delivery of pharmaceutical agents
AU2001262992A1 (en) * 2000-05-10 2002-02-18 University Of Kentucky Research Foundation System and method for intranasal administration of opioids
DE10064219B9 (de) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung

Also Published As

Publication number Publication date
CA2516338A1 (en) 2004-09-23
WO2004080382A3 (en) 2005-03-24
BRPI0408209A (pt) 2006-02-14
WO2004080382A2 (en) 2004-09-23
NO20054172D0 (no) 2005-09-07
AU2004218876B2 (en) 2007-08-02
JP2006519770A (ja) 2006-08-31
AU2004218876A1 (en) 2004-09-23
EP1608372A2 (de) 2005-12-28
KR20050115276A (ko) 2005-12-07
NO20054172L (no) 2005-10-06
NZ541781A (en) 2008-04-30

Similar Documents

Publication Publication Date Title
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
MXPA05012026A (es) Compuestos de azaindol como inhibidores de cinasa.
DE602004021472D1 (en) Pyrimiidinverbindungen
SE0101675D0 (sv) Novel composition
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
MX2007005221A (es) Formas cristalinas de ascomicina y preparacion de ellas.
IL188639A0 (en) Fentanyl formulation containing an essential oil
PH12013501567A1 (en) Anti-malarial pharmaceutical composition
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
ZA200604874B (en) Pharmaceutical compositions
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
AP1543A (en) Phenyl heterocyclyl ethers.
GB0327323D0 (en) Novel pharmaceuticals
MXPA05009602A (es) Composiciones novedosas.
TW200714596A (en) Isotopically substituted proton pump inhibitors
MY137965A (en) Semi-solid formulations for the oral administrations of taxoids
TNSN06013A1 (en) Semi-solid systems containing azetidine derivatives
WO2003099844A3 (en) Protease inhibitors
WO2003104257A3 (en) PROTEASE INHIBITORS
WO2003069998A8 (en) Stable compositions comprising tezacitabine
TW200505868A (en) New synerglstic combinations

Legal Events

Date Code Title Description
FA Abandonment or withdrawal